Study by Metagenomics and Culturomicsapproaches of Bacterial and Viral Flora of Diabetic Foot Infection
1 other identifier
observational
150
1 country
1
Brief Summary
This work also highlights the presence of an unknown virus double-stranded DNA. In this project we propose 1) incorporating a bank of 150 samples from patients with diabetic foot infection in grades 2-4; 2) to study the microbial flora of a selection of 50 diabetic feet previously untreated with antibiotics for bacterial metagenomics, viral metagenomics and a minimum of 10 per culturomique; 3) to evaluate the use of targeted quantitative PCR on the most frequent new species frequency in the disease and incidentally get a sense of their role in the evolution and prognosis of the disease, including failures of and targeted antibiotic therapy on all 150 samples.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
September 30, 2015
CompletedFirst Posted
Study publicly available on registry
October 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedOctober 1, 2015
September 1, 2015
3 years
September 30, 2015
September 30, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
dermal sample
36 months
Study Arms (1)
diabetic patient with foot infection
Interventions
Eligibility Criteria
diabetic patient with foot infection
You may qualify if:
- Patients were taken care by the services(departments) of Diabetology or Infectious diseases of the CHU(TEACHING HOSPITAL) of Nîmes, were hospitalized or were seen in consultation and presenting a wound chronicle of the foot and/or the ankle of Rank 2 - 4 (Classification of the IWGDF) \[IWGDF, Lipsky Clin Infect Dis on 2004\], inaugural or récidivante.
You may not qualify if:
- The patient participates in another study
- The patient is under protection(saving) of justice, under guardianship or under guardianship
- The patient refuses to sign the consent
- It turns out impossible to give about the lit(enlightened) information
- The patient is pregnant, parturiente, or she breast-feeds
- The patients having no wound
- The patients diabetics having a wound chronicles of Rank 1 (Classification of the IWGDF) \[IWGDF, Lipsky Clin Infect Dis on 2004\]
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assistance Publique Hopitaux de Marseille
Marseille, Paca, 13354, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
desalbres urielle
Assistance Publique Hopitaux De Marseille
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 30, 2015
First Posted
October 1, 2015
Study Start
December 1, 2014
Primary Completion
December 1, 2017
Last Updated
October 1, 2015
Record last verified: 2015-09